Skip to main content
. 2008 Apr 24;84(1):302–310. doi: 10.1189/jlb.0208090

Fig. 5.

Fig. 5.

MDA-MB-231 human Nrp1+ breast cancer cells bind and activate latent TGF-β1. (A) Incubation of the cells with LAP-TGF-β1 and fluorescent LAP staining showing retention of LAP. (B) Cells treated with anti-Nrp1 mAb-blocking antibody and LAP-TGF-β1 and stained for LAP. (C) p-Smad2 fluorescent staining of untreated cultured cells. (D) p-Smad2 staining of cells incubated with LAP-TGF-β1. (E) p-Smad2 staining of cells incubated with anti-Nrp1 antibody and LAP-TGF-β1. (F) p-Smad2 staining of cells incubated with SD-208 and LAP-TGF-β1. The results of A–F are representative of three separate experiments.